Zeyyer Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 286.98%
- Profit Growth 731.01%
- Ebitda 135.42%
- Net Worth 115.95%
- Total Assets 11.84%
About Zeyyer Pharmaceuticals
Zeyyer Pharmaceuticals Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2018 (Six years and seven months 0 days old ). Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Shabeer Yakath, Alihassan Kurukkan, and Anseera Thesneem serve as directors at the Company.
Company Details
-
Location
Kozhikode, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119KL2018PTC053957
-
Company No.
053957
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jul 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Zeyyer Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shabeer Yakath
|
Managing Director | 09-Jul-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Alihassan Kurukkan
|
Director | 09-Jul-2018 | Current |
|
Anseera Thesneem
|
Director | 28-Jan-2021 | Current |
Financial Performance of Zeyyer Pharmaceuticals.
Zeyyer Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 286.98% increase. The company also saw a substantial improvement in profitability, with a 731.01% increase in profit. The company's net worth Soared by an impressive increase of 115.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeyyer Pharmaceuticals?
Unlock access to Zeyyer Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Healfort Hospitals LlpShabeer Yakath is a mutual person
-
Hawit Gastro Center Llp
Shabeer Yakath is a mutual person
-
Astriogenix Life Sciences Private Limited
Shabeer Yakath and Alihassan Kurukkan are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2024 | Hdfc Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Zeyyer Pharmaceuticals?
Unlock and access historical data on people associated with Zeyyer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeyyer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeyyer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.